Molecular and Serological Tests for COVID-19. A Comparative Review of SARS-CoV-2 Coronavirus Laboratory and Point-of-Care Diagnostics

Citations Over TimeTop 10% of 2020 papers

Abstract

Validated and accurate laboratory testing for Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) is a crucial part of the timely management of Coronavirus Disease 2019 (COVID-19) disease, supporting the clinical decision-making process for infection control at the healthcare level and detecting asymptomatic cases. This would facilitate an appropriate treatment, a prompt isolation and consequently deceleration of the pandemic. Various laboratory tests can identify the genetic material of SARS-CoV-2 that causes COVID-19 in specimens, or specific anti-viral antibodies in blood/serum. Due to the current pandemic situation, a development of point-of-care diagnostics (POCD) allows us to substantially accelerate taking clinical decisions and implement strategic planning at the national level of preventative measures. This review summarizes and compares the available POCD and those currently under development, including quantitative reverse transcription PCR (RT-qPCR), serology immunoassays (SIAs) and protein microarray method (PMM) designed for standard and rapid COVID-19 diagnosis.

Related Papers

• → Personal protective equipment in an influenza pandemic: a UK simulation exercise(2008)62 cited
• → Field-testing and validation in a primary care setting of a point-of-care test for C-reactive protein(2003)41 cited
• → COVID-19 Pandemic: International Variation of Personal Protective Equipment and Infection Prevention and Control Guidelines(2020)17 cited
• Principles & practice of point-of-care testing(2002)
• → 3. Point of Care: Useful Clinical Examination and Ultrasonography, 1) Clinical Laboratory Test: Point of Care Testing, Cardiac Marker (Mainly Cardiac Troponin)(2019)